All In MedTech

Company

Anika

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Anika, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Anika.

Latest FDA decisions

The 8 newest of 11 since 2015.

Search the Clearance Tracker

8 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT06741527 · 150 participants (planned) · Start Feb 1, 2025 · Primary completion Jun 2027

    Device: Integrity Implant System · For: Rotator Cuff Tears of the Shoulder

    Sites: Gilbert, Arizona; Pomona, California; Tampa, Florida · 9 sites in all

  • NCT02659215 · 200 participants · Start Dec 2015 · Primary completion Mar 20, 2025

    Device: Hyalofast · For: Defect of Articular Cartilage

    Sites: Tempe, Arizona; Los Angeles, California; San Diego, California · 48 sites in all

  • NCT04204278 · 25 participants · Start Dec 11, 2019 · Primary completion Feb 26, 2021

    Device: Monovisc · For: Osteoarthritis Ankle

    Sites: Ústí nad Labem, Czechia; Gliwice, Poland; Lodz, Poland · 4 sites in all

12 more trials with a free account

Reports received

33

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

3

9.1% of reports

Injury reports

30

91% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230100
Jan 240100
Feb 240200
Mar 242110
Apr 240111
May 242100
Jun 240210
Jul 242500
Aug 240300
Sep 241200
Oct 241300
Nov 240000
Dec 240200
Jan 251100
Feb 250010
Mar 252000
Apr 251010
May 250010
Jun 250200
Jul 250110
Aug 250310
Sep 250200
Oct 250500
Nov 250000
Dec 253100
Jan 260200
Feb 260500
Mar 260000
Apr 260100
May 260000
Jun 260300
Jul 260500
Aug 260600
Sep 260600
Oct 260100
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

1 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

10 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.